Trial · NCT01192867
Registered outcomes29
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 29
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in the Positive and Negative Symptoms Scales (PANSS) Negative Symptoms Factor Score at Week 24 (All-Participant Population) | Baseline, Week 24 | |
| Primary | Percentage of Participants With Adverse Events (All-Participant Population) | Week 24 | |
| Secondary | Change From Baseline in the PANSS Negative Symptoms Factor Score at Week 24 (Complement Factor H Related Protein 1 High [CFHR1-High] Subgroup Population) | Baseline, Week 24 | |
| Secondary | Change From Baseline in the Personal and Social Performance (PSP) Total Score at Week 24 (All-Participant Population) | Baseline, Week 24 | |
| Secondary | Change From Baseline in the PSP Total Score at Week 24 (CFHR1-High Subgroup Population) | Baseline, Week 24 | |
| Secondary | Change From Baseline in the PANSS Total Score at Week 24 (All-Participant Population) | Baseline, Week 24 | |
| Secondary | Change From Baseline in the PANSS Total Score at Week 24 (CFHR1-High Subgroup Population) | Baseline, Week 24 | |
| Secondary | Change From Baseline in the PANSS Factor Score at Week 24 (All-Participant Population) | Baseline, Week 24 | |
| Secondary | Change From Baseline in the PANSS Factor Score at Week 24 (CFHR1-High Subgroup Population) | Baseline, Week 24 | |
| Secondary | Change From Baseline in the PANSS Subscale Scores at Week 24 (All-Participant Population) | Baseline, Week 24 | |
| Secondary | Change From Baseline in the PANSS Subscale Scores at Week 24 (CFHR1-High Subgroup Population) | Baseline, Week 24 | |
| Secondary | Percentage of Participants Who Have at least 20 Percent (%) Improvement From Baseline in the PANSS Negative Symptom Factor Score at Week 24 (All-Participant Population) | Baseline, Week 24 | |
| Secondary | Percentage of Participants Who Have at least 20% Improvement From Baseline in the PANSS Negative Symptom Factor Score at Week 24 (CFHR1-High Subgroup Population) | Baseline, Week 24 | |
| Secondary | Percentage of Participants Who Have at least 20% Improvement From Baseline in the PANSS Negative Symptom Factor Score for Two out of Three Assessments During 24 Weeks (All-Participant Population) | Baseline up to Week 24 | |
| Secondary | Percentage of Participants Who Have at least 20% Improvement From Baseline in the PANSS Negative Symptom Factor Score for Two out of Three Assessments During 24 Weeks (CFHR1-High Subgroup Population) | Baseline up to Week 24 | |
| Secondary | Percentage of Participants With Improvement From Baseline in the Overall Clinical Status Based on Clinical Global Impression - Improvement (CGI-I) Score (All-Participant Population) | Baseline, Week 24 | |
| Secondary | Percentage of Participants With Improvement From Baseline in the Overall Clinical Status Based on CGI-I Score (CFHR1 Subgroup Population) | Baseline, Week 24 | |
| Secondary | Percentage of Participants With Improvement From Baseline in the Overall Clinical Status Based on CGI-I Score for Two out of Three Assessments During 24 Weeks (All-Participant Population) | Baseline up to Week 24 | |
| Secondary | Percentage of Participants With Improvement From Baseline in the Overall Clinical Status Based on CGI-I Score for Two out of Three Assessments During 24 Weeks (CFHR1 Subgroup Population) | Baseline up to Week 24 | |
| Secondary | Percentage of Participants With Improvement From Baseline in the Negative Symptoms Based on CGI-I Negative Symptoms Score (All-Participant Population) | Baseline, Week 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01192867/registered